Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
08/23/2001 | WO2001060398A1 Drugs for ameliorating impaired glucose tolerance |
08/23/2001 | WO2001060390A1 New toralactone and its derivation and the use of decreasing blood-fat and losing weight |
08/23/2001 | WO2001060384A1 Inhibition of mal-1, the keratinocyte lipid binding protein |
08/23/2001 | WO2001060381A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
08/23/2001 | WO2001060379A1 Nucleoside analogs with carboxamidine modified monocyclic base |
08/23/2001 | WO2001060377A2 Methods for treatment of lysosomal storage diseases using biphosphonates |
08/23/2001 | WO2001060363A1 A method for synthesizing leflunomide |
08/23/2001 | WO2001060319A2 Polyhydroxylated benzene-containing compounds |
08/23/2001 | WO2001060176A1 Inulin products with improved nutritional properties |
08/23/2001 | WO2001060174A2 Weight loss induced by reduction in neuropeptide y level |
08/23/2001 | WO2001060152A2 Transgenic non-human ucp2 knockout mammal |
08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
08/23/2001 | WO2001012775A3 25 human secreted proteins |
08/23/2001 | WO2001005356A3 Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant |
08/23/2001 | WO2001004116A3 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
08/23/2001 | WO2000078266A3 Interferon tau mutants and methods for making them |
08/23/2001 | WO2000059484A3 Use of arylalkanoylpyridazines |
08/23/2001 | US20010016661 Indolealkanoic acid derivatives inhibits aldose reductase and useful for treating chronic complication associated with diabetes mellitus including diabetic cataracts, retinopathy, nephropathy and neuropathy |
08/23/2001 | US20010016603 Calcium formate for use as a dietary supplement |
08/23/2001 | US20010016596 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
08/23/2001 | US20010016586 Use of organic compounds |
08/23/2001 | US20010016576 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
08/23/2001 | US20010016570 Bone disorders |
08/23/2001 | US20010016568 Zinc chelate dimeric cell surface receptor antagonist |
08/23/2001 | US20010016355 Genetic engineering |
08/23/2001 | US20010016336 Genetic engineered polypeptide |
08/23/2001 | US20010016218 Method for production of arachidonic acid |
08/23/2001 | US20010016207 Compounds such as N-(1-(cyanomethylcarbamoyl)cyclohexyl)-4-(piperazin-1-yl)-benzamide |
08/23/2001 | EP1143944A3 Use of arylalkanoylpyridazines |
08/23/2001 | DE10038110A1 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |
08/23/2001 | CA2651825A1 Substituted arylpyrazines |
08/23/2001 | CA2400860A1 Aminoalcohol derivatives |
08/23/2001 | CA2400631A1 Beta-alanine derivatives and their use as receptor antagonists |
08/23/2001 | CA2400619A1 Purine derivatives |
08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
08/23/2001 | CA2400355A1 Pancreatic islet cell growth factors |
08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
08/23/2001 | CA2400290A1 A method for synthesizing leflunomide |
08/23/2001 | CA2400136A1 Weight loss induced by reduction in neuropeptide y level |
08/23/2001 | CA2400101A1 Human protein tyrosine phosphatase, encoding dna and uses thereof |
08/23/2001 | CA2400034A1 Human kinases |
08/23/2001 | CA2400021A1 Aryloxyacetic acids for diabetes and lipid disorders |
08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
08/23/2001 | CA2395854A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
08/23/2001 | CA2395473A1 Microcompetiton and human disease |
08/23/2001 | CA2371419A1 Polyhydroxylated benzene-containing compounds |
08/22/2001 | EP1125944A1 Pluraflavin and derivatives thereof, process for making them as well as their use |
08/22/2001 | EP1125932A2 Substituted thiazoles for the treatment of inflammation |
08/22/2001 | EP1125929A1 Method for making (-)-(2R,4S)-4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester |
08/22/2001 | EP1125584A1 Betacellulin protein-containing preparations |
08/22/2001 | EP1125580A2 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
08/22/2001 | EP1125579A2 Uses of agrp-melanocortin receptor binding modulating compounds |
08/22/2001 | EP1125507A1 Inulin products with improved nutritional properties |
08/22/2001 | EP1124983A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |
08/22/2001 | EP1124850A1 12 human secreted proteins |
08/22/2001 | EP1124845A2 Phosphinate peptide analogs for the treatment of fibrotic disorders |
08/22/2001 | EP1124809A1 Benzoylpyridazines |
08/22/2001 | EP1124801A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
08/22/2001 | EP1124794A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
08/22/2001 | EP1124779A1 Vitamin d analogues |
08/22/2001 | EP1124592A2 Textured and porous silicone rubber |
08/22/2001 | EP1124572A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
08/22/2001 | EP1124571A1 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia |
08/22/2001 | EP1124569A2 Composition and method for increasing weight gain and feed efficiency |
08/22/2001 | EP1124564A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
08/22/2001 | EP1124444A1 Sweetener |
08/22/2001 | EP0907633B1 New synthetic catechol derivatives, method for production and use thereof |
08/22/2001 | EP0825871B1 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids |
08/22/2001 | EP0764204B1 HUMAN OXALYL-CoA DECARBOXYLASE |
08/22/2001 | EP0626851B1 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the preparation of a medicament for the treatment of certain types of pain and of oedema |
08/22/2001 | CN1309666A Polymer composition of glucuronic acid glucosan |
08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
08/22/2001 | CN1309657A Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors |
08/22/2001 | CN1309655A Cyclic compounds useful in treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
08/22/2001 | CN1309653A Polycyclic thiazolidin-2-ylidene amines, method for production and use thereof as medicaments |
08/22/2001 | CN1309649A Polyhydroalkylpyrazine derivs. and their preparation and medicines contg. them |
08/22/2001 | CN1309641A Quinoline derivs. |
08/22/2001 | CN1309640A Quinoline derivs. |
08/22/2001 | CN1309556A Biodegradable sustained-release alginate gels |
08/22/2001 | CN1309133A Neotoralactone, its derivatives and their application in reducing fat and lossing weight |
08/22/2001 | CN1308954A Oral liquid for treating diabetes and its preparing process |
08/22/2001 | CN1308949A Medicine for treating diabetes and its preparing process |
08/22/2001 | CN1308946A Chinese patent medicine for treating coronary heart disease and hypertension |
08/22/2001 | CN1308942A Tea for beautifying face and lossing weight |
08/22/2001 | CN1069901C N-benzyldioxothiazolidylbenzamide derivs. and process for producing same |
08/22/2001 | CN1069829C Percutaneous applied medicine contg. gestodene |
08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
08/21/2001 | US6277887 Methods for treating Parkinson's disease using optically pure (−)-bupropion |
08/21/2001 | US6277869 Pharmaceutical composition |
08/21/2001 | US6277852 Piperazinyl 5-HT1 agonists and antagonists |
08/21/2001 | US6277831 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use |
08/21/2001 | US6277819 Use of GLP-1 or analogs in treatment of myocardial infarction |
08/21/2001 | US6277586 Used for detecting the presence of autoantibodies to glutamic acid decarboxylaes (gad) in a biological sample |
08/21/2001 | US6277405 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
08/21/2001 | US6277366 Noncrosslinked quaternized aminoalkyl acrylate anion exchange resins, antilipemic agent |
08/21/2001 | CA2294595C Inhibiting bone resorption |
08/21/2001 | CA2207348C Benzimidazole derivatives |
08/21/2001 | CA2100868C Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions forenteral and parenteral nutrition |